Page last updated: 2024-08-26

combretastatin and Cancer of Ovary

combretastatin has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gore, M; Gourley, C; Hall, M; Jayson, G; Kaye, S; Ledermann, J; McNeish, I; Perren, T; Rustin, G	1

Reviews

1 review(s) available for combretastatin and Cancer of Ovary

Article	Year
Targeted anti-vascular therapies for ovarian cancer: current evidence. British journal of cancer, 2013, Feb-05, Volume: 108, Issue:2 Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bibenzyls; Female; Fibroblast Growth Factors; Flavonoids; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Ovarian Neoplasms; Thrombospondins; Treatment Outcome; Vascular Endothelial Growth Factors	2013

Article

Year

Targeted anti-vascular therapies for ovarian cancer: current evidence.

British journal of cancer, 2013, Feb-05, Volume: 108, Issue:2

Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bibenzyls; Female; Fibroblast Growth Factors; Flavonoids; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Ovarian Neoplasms; Thrombospondins; Treatment Outcome; Vascular Endothelial Growth Factors

2013